KFF Health News December 2, 2024
Melba Newsome

After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don’t work.

So when the University of North Carolina-Charlotte professor learned that Ozempic — developed to treat Type 2 diabetes — helped people lose weight and keep it off, Blanchard was determined to try it.

The state employee’s health insurance initially covered the prescription with Blanchard kicking in a $25 copayment. Over the next seven months, she said, she lost 45 pounds and lowered her blood pressure and cholesterol. The most significant benefits, though, were psychological.

“It stopped the food noise in my head, relieved my anxiety, and I was no longer drinking like a fish,” said Blanchard, now 60. “I’d...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicaid, Patient / Consumer, Pharma / Biotech, States
Are Telehealth Reimbursement Policies Strangling FQHCs?
GOP Takes Aim at Medicaid, Putting Enrollees and Providers at Risk
Medicaid cuts could worsen home care worker shortage: KFF
Trump’s mixed Medicaid messaging
Value-based payment models: Doctors describe the disconnect between theory and practice

Share This Article